Ibiglustat (Venglustat) is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat can be used for the research of Gaucher disease type 3, Parkinsons disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis
Molecular Weight:
389.49
Purity:
99.81
CAS Number:
[1401090-53-6]
Formula:
C20H24FN3O2S
Target:
Glucosylceramide Synthase (GCS)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted